Beta Bionics (NASDAQ:BBNX) executives used a conference presentation to outline the company’s strategy in insulin delivery, ...

PARSIPPANY, N.J., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Embecta Corp. ("embecta") (Nasdaq: EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, today announced it has ...

One of the diabetes market’s newest spinoffs is set to undergo a significant change. Embecta, which was spun out of Becton Dickinson in April of 2022, is instituting a restructuring plan that includes ...

SAN DIEGO, CA / ACCESS Newswire / November 17, 2025 / Modular Medical, Inc. (MODD) ("Modular Medical" or the "Company"), a leader in innovative insulin delivery technology targeting the $3 billion ...

Embecta Corp., a global diabetes care company, recently announced it has received 510(k) clearance from the U.S. Food and Drug Administration for its disposable insulin delivery system. Indicated for ...

The MarketWatch News Department was not involved in the creation of this content. Insulin Delivery Devices Market Surges to USD 43.11 Billion by 2033 as Smart Pumps, Automated Systems & Digital ...

SAN DIEGO, CA / / March 3, 2026 / Modular Medical, Inc. (NASDAQ:MODD) ("Modular Medical" or the "Company"), an insulin ...

Cartridge & Infusion Set Lots in Production: Validation production lots now being produced for launch, derisking commercial-scale production. First Removable Tubeless Patch Pump: Pivot targets ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Higher consumption of rye, oats and fruits increased the ...

While 9 out of 10 people with diabetes are living with T2D, many of the automated insulin delivery solutions currently on the market were designed for people living with T1D. 300-unit insulin ...